However, women carrying BRCA2 mutations show clinical courses with better prognoses than those carrying BRCA1 mutations, in terms of a longer time to first relapse as well as fewer relapses, but both carriers showed higher survival rates than expected for the stage and grade of their cancers [47]. Here, BRCA2 is linked to cancer.